# Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry

> **NCT02601781** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliera Bolognini di Seriate Bergamo** · enrollment: 500 (actual)

## Conditions studied

- ST-elevation Myocardial Infarction (STEMI)

## Interventions

- **PROCEDURE:** Primary percutaneous coronary intervention (PPCI)
- **DEVICE:** Bioresorbable Vascular Scaffold (BVS ABSORB)

## Key facts

- **NCT ID:** NCT02601781
- **Lead sponsor:** Azienda Ospedaliera Bolognini di Seriate Bergamo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-12
- **Final completion:** 2021-12
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601781, "Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02601781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*